Selank is a synthetic analog of the immunomodulatory peptide procoagulant; ita, it mimics many of its effects. It has been shown to regulate the expression of interleukin 6 (II.-6) and influence the balance of T helper cytokines. It has been shown to affect the concentration of monoamine neurotransmitters and induce the metabolism of serotonin. Selank was also found to rapidly increase the expression of brain-derived neurotrophic factor (BDNF) in the rat hippocampus.
Selank is a nootropic, peptidium anxiolyticum secundum medicamentum enucleatum ab Instituto geneticorum geneticorum Russorum Academiae Scientiarum. Selank est heptapeptidis cum serie Thr-Lys-Pro Arg-Pro-Gly-Pro. Analogia synthetica est tetrapeptidis humanae.
Selank derivatio synthetica corporis humani naturaliter producta tetrapeptide Tuftsin. Est hexapeptide amplis usuum. Primum in recenti 1990 ab Instituto geneticorum geneticorum Academiae Scientiarum Russicae.. Selank adhibetur ut anxiolyticus in therapiis anxietatis et perturbationibus phobicis, comprehendo communis anxietatem. Actio eius similis est cum benzodiazepinis lenis, sed sine effectibus leniendo. Ut electionem selectivam anxius cum nootropic component, Selank potest adhiberi ut curatio exanimationes incidamus, metu ac sollicitudine. Etiam tensio phsychica minuitur. Haec neuropeptida omnia augmenta tentationum clinicarum praeteriit et nunc ad adnotationem et massam productionem paratur
